Development of Biarylalkyl Carboxylic Acid Amides with Improved Anti‐schistosomal Activity

The parasitic disease schistosomiasis is the cause of more than 200 000 human deaths per year. Although the disease is treatable, there is one major shortcoming: praziquantel has been the only drug used to combat these parasites since 1977. The risk of the emergence of resistant schistosomes is know...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ChemMedChem
Autors principals: Peter Ventura, Alejandra M., Haeberlein, Simone, Lange‐Grünweller, Kerstin, Grünweller, Arnold, Hartmann, Roland K., Grevelding, Christoph G., Schlitzer, Martin
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Full Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7687077/
https://ncbi.nlm.nih.gov/pubmed/31454168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.201900423
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars